Characteristics of Long-Term Survivors following Sorafenib Treatment for Advanced Hepatocellular Carcinoma: Report of a Workshop at the 50th Annual Meeting of the Liver Cancer Study Group of Japan

Publisher： Karger

E-ISSN： 1423-0232|87|1|104-109

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.1, 2014-11, pp. : 104-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in the Management of Hepatocellular Carcinoma: Consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Pancreatic Atrophy in Hepatocellular Carcinoma Patients Receiving Long-Term Treatment with Sorafenib

By  

Oncology, Vol. 89, Iss. 2, 2015-04 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Rapid Regression of Advanced Hepatocellular Carcinoma Associated with Elevation of Des-Gamma-Carboxy Prothrombin after Short-Term Treatment with Sorafenib – A Report of Two Cases

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-08 ,pp. : 298-303

Karger

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update

By  

Oncology, Vol. 87, Iss. 1, 2014-11 ,pp. : 7-21

Karger

Access to resources Recommend Favorite